Cronos (CRON) Non Operating Investment Income (2019 - 2024)
Cronos' (CRON) quarterly Non Operating Investment Income came in at $32.5 million in Q3 2024, up 70484.78% quarter-over-quarter from $46000.0 in Q4 2020.
Cronos (CRON) Non Operating Investment Income (2019 - 2024) Analysis & Trends
Cronos' Non Operating Investment Income history runs 3 years deep, the most recent figure standing at $32.5 million for Q3 2024.
- On a quarterly basis, Non Operating Investment Income changed N/A year-over-year to $32.5 million in Q3 2024; TTM through Dec 2025 was $32.5 million, a 0.0% change from a year earlier, with the FY2024 full-year figure at $32.5 million, changed N/A from the prior year.
- Non Operating Investment Income grew to $32.5 million in Q3 2024 per CRON's latest filing, from $46000.0 in the prior quarter.
- Across five years, Non Operating Investment Income topped out at $32.5 million in Q3 2024 and bottomed at $46000.0 in Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Investment Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | - |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | - |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | - |
| 10 | Cronos | 1.08 Bn | 261.26 Mn | 19.15 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 32.47 Mn |
| Sep 30, 2024 | 32.47 Mn |
| Dec 31, 2020 | 46,000.00 |
| Dec 31, 2020 | 46,000.00 |
| Sep 30, 2020 | 3.97 Mn |
| Sep 30, 2020 | 3.97 Mn |
| Dec 31, 2019 | 35,000.00 |
| Dec 31, 2019 | 35,000.00 |